Skip to main content
. 2019 May 23;10(6):978–984. doi: 10.1021/acsmedchemlett.9b00170

Figure 4.

Figure 4

(A) Detection of SMYD3 and MAP3K2-me2/me3 in HepG2 cells using Western blot analysis. (B) Reduction of MAP3K2-me2/me3 using different HepG2 clones with SMYD3 knockout. (C) Inhibition of proliferation of HepG2 cells in anchorage-independent condition.